FDA NDC Directory · JSON-LD · Markdown

Hydroxyzine Pamoate

NDC 76420-920 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerAsclemed USA, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA088496
Dosage form / routeCAPSULE · ORAL
Active ingredientsHYDROXYZINE PAMOATE (25 mg/1)
Marketing started19840701
Package count5

External sources

Source: openFDA. Public-domain (CC0).